Cannamedical Pharma GmbH has received a major investment from the US venture capital fund Orkila Capital.
Founded in 2016, Cannamedical Pharma GmbH has been trading medical cannabis since legalisation in March 2017 and supplies it to medical doctors and pharmacies. Cannamedical Pharma GmbH is one of the leading cannabis wholesalers and one of the best-known medical cannabis brands in Germany.
Orkila Capital is a US venture capital fund. With this investment, Orkila Capital acquires a minority stake in Cannamedical Pharma GmbH.
The venture capital group of Seitz has managed to successfully implement a further major financing round. Seitz regularly acts for founders and start-ups as well as VC and corporate investors.
Advisor Cannamedical Pharma GmbH
Seitz: Dr. Daniel Grewe, Dr. Wolfgang Schüler, Dr. Florian Lauscher, Dr. Jennifer Konrad, Maximilian V. Otto Houf (all Corporate/M&A), Christian Schmitt (IP/IT), Christoph Frey (Tax), Dr. Johannes Traut (Data Protection)